Provided by Tiger Trade Technology Pte. Ltd.

Mirum Pharmaceuticals, Inc.

101.28
-1.8200-1.77%
Volume:162.17K
Turnover:16.57M
Market Cap:6.06B
PE:-120.67
High:103.64
Open:102.47
Low:101.00
Close:103.10
52wk High:105.74
52wk Low:36.88
Shares:59.88M
Float Shares:39.99M
Volume Ratio:1.45
T/O Rate:0.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8393
EPS(LYR):-1.8505
ROE:-15.81%
ROA:-3.60%
PB:20.77
PE(LYR):-54.73

Loading ...

Mirum Pharmaceuticals Grants Stock Options and Equity Awards to New Employees

Reuters
·
Feb 11

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Feb 11

Mirum Pharmaceuticals Announces Health Canada Authorization of Livmarli® Tablet Formulation for the Treatment of Cholestatic Pruritus in Patients With Alagille Syndrome

THOMSON REUTERS
·
Feb 05

Health Canada genehmigt LIVMARLI von Mirum Pharmaceuticals zur Behandlung von cholestatischem Pruritus bei PFIC

Reuters
·
Feb 05

Mirum Pharmaceuticals Announces Health Canada Authorization of Livmarli® for the Treatment of Cholestatic Pruritus in Patients With Progressive Familial Intrahepatic Cholestasis (Pfic)

THOMSON REUTERS
·
Feb 05

Mirum Pharmaceuticals Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Jan 31

Mirum Pharmaceuticals Inc : TD Cowen Raises Target Price to $115 From $95

THOMSON REUTERS
·
Jan 29

Mirum Pharmaceuticals director buys $9.0M in common stock

TIPRANKS
·
Jan 28

Mirum Pharmaceuticals CEO Christopher Peetz Reports Disposal of Common Shares

Reuters
·
Jan 28

Mirum Pharmaceuticals Completes Acquisition of Bluejay Therapeutics

Reuters
·
Jan 26

Mirum Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jan 26

Mirum Pharmaceuticals Inc : Leerink Partners Raises Target Price to $105 From $100

THOMSON REUTERS
·
Jan 26

Mirum Pharmaceuticals price target raised to $130 from $102 at H.C. Wainwright

TIPRANKS
·
Jan 26

HBM Healthcare Investments Reports CHF 286 Million Profit for First Nine Months of 2025/2026

Reuters
·
Jan 23

Evercore ISI Reaffirms Their Buy Rating on Mirum Pharmaceuticals (MIRM)

TIPRANKS
·
Jan 20

Mirum Pharmaceuticals (MIRM) Is Up 5.2% After Issuing Confident 2026 Revenue Outlook and Pipeline Update

Simply Wall St.
·
Jan 19

A Look At Mirum Pharmaceuticals (MIRM) Valuation After Strong Recent Share Price Momentum

Simply Wall St.
·
Jan 18

Director Saira Ramasastry Reports Disposal of Mirum Pharmaceuticals Common Shares

Reuters
·
Jan 17

Mirum Pharmaceuticals Price Target Raised to $102.00/Share From $81.00 by HC Wainwright & Co.

Dow Jones
·
Jan 13

Mirum Pharmaceuticals price target raised to $102 from $81 at H.C. Wainwright

TIPRANKS
·
Jan 13